Search - tctmd.com

Displaying 281 - 300 of 415

Sort: Relevancy | Date

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

Presentation TCT 2014

TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study

Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Ajay J. Kirtane

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

就在接受PCI前的阿司匹林高反应性导致结果更差

September 02, 2014

News Daily News

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

September 02, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

Advertisement

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

就在接受PCI前的阿司匹林高反应性导致结果更差

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content